Australia Plans National H1N1 Shots For All In October
This article was originally published in PharmAsia News
Executive Summary
Although the medicine eventually being used is still undergoing testing, Australia's chief medical officer said a national vaccination program against the H1N1 flu virus is set to begin in October. The government has ordered 21 million doses of the vaccine, enough to inoculate the entire population with one dose. Professor Jim Bishop said the government expects the H1N1 virus to linger in Australia beyond the end of the flu season because of a second wave of the virus expected to be more severe than the first one being felt now. (Click here for more
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.